Cherry Creek Investment Advisors, Inc.

Position in AMGN — Amgen Inc

CIK 1877829 ENGLEWOOD, CO

Position in AMGN

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$279,556

+$12,502 QoQ

Shares Held

772

+1.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#2,601

of 3,140 holders

Holding Since

Dec 2021

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cherry Creek Investment Advisors, Inc. holds $9,772,035 across 6 Drug Manufacturers - General names. AMGN ranks #6 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	27,564	$6,936,204
2	GILD	Gilead Sciences, Inc.	8,954	$1,131,248
3	PFE	Pfizer Inc	24,153	$581,604
4	BMY	Bristol Myers Squibb Co	9,754	$562,025
5	JNJ	Johnson & Johnson	1,108	$281,398
6	AMGN	Amgen Inc This page	772	$279,556

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$279,556	772	+1.7%	Shares	Sole	2026-07-30
2026-03-31	$267,054	759	+1.3%	Shares	Sole	2026-04-30
2025-12-31	$245,155	749	+0.4%	Shares	Sole	2026-01-15
2025-09-30	$210,521	746	-4.1%	Shares	Sole	2025-11-05
2024-09-30	$250,679	778	+0.4%	Shares	Sole	2024-10-22
2024-06-30	$242,148	775	-8.7%	Shares	Sole	2024-07-18
2024-03-31	$241,387	849	-10.3%	Shares	Sole	2024-04-23
2023-12-31	$272,466	946	+0.4%	Shares	Sole	2024-01-26
2023-09-30	$253,171	942	+0.2%	Shares	Sole	2023-10-13
2023-06-30	$208,698	940	+0.5%	Shares	Sole	2023-07-14
2023-03-31	$226,036	935	+0.3%	Shares	Sole	2023-04-24
2022-12-31	$244,780	932	-5.7%	Shares	Sole	2023-02-10
2022-09-30	$222,695	988	+0.3%	Shares	Sole	2022-10-24
2022-06-30	$239,650	985	+0.4%	Shares	Sole	2022-07-20
2022-03-31	$237,225	981	+0.3%	Shares	Sole	2022-04-22
2021-12-31	$220,020	978	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.